Geraldine Paulus

Company: Crossbow Technology Inc

Job title: VP of Corporate Development and Operations

Seminars:

CBX-250: A First-in-Class TCR-Mimetic-Based T-Cell Engager for the Treatment of Myeloid Leukemia 4:05 pm

Introduce a novel TCR-mimetic based T-cell engager against a novel target in AML and other myeloid malignancies Discuss the preclinical characterization strategy and results of target safety, binder potency, binder specificity and TCE developabilityRead more

day: Conference Day Two